Compare STOK & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | ENR |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2019 | N/A |
| Metric | STOK | ENR |
|---|---|---|
| Price | $33.14 | $17.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $31.00 | $27.00 |
| AVG Volume (30 Days) | 880.4K | ★ 1.8M |
| Earning Date | 11-04-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | ★ 538.46 |
| EPS | 0.68 | ★ 3.32 |
| Revenue | $205,632,000.00 | ★ $2,952,700,000.00 |
| Revenue This Year | $430.24 | $2.41 |
| Revenue Next Year | N/A | $1.09 |
| P/E Ratio | $45.09 | ★ $5.41 |
| Revenue Growth | ★ 1128.17 | 2.28 |
| 52 Week Low | $5.35 | $16.77 |
| 52 Week High | $38.69 | $38.33 |
| Indicator | STOK | ENR |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 34.29 |
| Support Level | $28.74 | $16.77 |
| Resistance Level | $31.44 | $18.94 |
| Average True Range (ATR) | 1.83 | 0.98 |
| MACD | 0.38 | 0.05 |
| Stochastic Oscillator | 95.76 | 35.10 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.